Precision BioSciences (DTIL) Tops Q1 EPS by 17c

Precision BioSciences (NASDAQ: DTIL) reported Q1 EPS of ($0.33), $0.17 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $16.35 million versus the consensus estimate of $7.11 million.

For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• InspireMD (NSPR) Tops Q2 EPS by 1c
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'